British Columbia eye drug policy seen as controversial

CBC News (11/25) reports that patients with age-related macular degeneration (AMD) in British Columbia “are in a quandary over a provincial policy that allows doctors to profit by using” Avastin [bevacizumab], “a medication that’s much cheaper than the approved drug,” Lucentis [ranibizumab]. “In June, BC started to pay for treatments with Lucentis,” which “costs $1,575 for a vial that provides three doses,” but “Avastin is just as effective as Lucentis at treating” AMD, “according to a US study,” and costs far less. Dr. Alan Cruess, past president of the Canadian Ophthalmological Society, “met with BC Health Minister Kevin Falcon and urged him to stop paying doctors to inject Avastin,” asking, “Are we just going to just use whatever the cheapest drug is?” More information click here

Advertisements

One Response

  1. […] British Columbia eye drug policy seen as controversial – Lucentis is approved but Avastin is apparently used. […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: